| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/06/1999 | US5891677 Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof |
| 04/06/1999 | US5891676 Recombinant molecule which contains baculovirus promoter spatially positioned with rotovirus protein vp2 gene; effective gene regulation; vaccine for animals and humans against diarrheal disease |
| 04/06/1999 | US5891675 TNF receptor death domain ligand proteins |
| 04/06/1999 | US5891674 The use of these sequences in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with insulin response. |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891671 Method for cleaving chimeric protein using processing enzyme |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/06/1999 | US5891669 Methods for producing polypeptides in respiratory-deficient cells |
| 04/06/1999 | US5891668 Nucleic acid encoding tumor suppresssor gene 101 protein; diagnosis early cancer detection, therapy of cancers, drug screening |
| 04/06/1999 | US5891667 SpoIIIe polynucleotides |
| 04/06/1999 | US5891666 Genes encoding LSIRF polypeptides |
| 04/06/1999 | US5891665 Rna subsequence comprising a 5' signal sequence of a non-structural gene linked to a second heterologous sequence downstream; enhanced for increased protein production |
| 04/06/1999 | US5891664 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR) |
| 04/06/1999 | US5891655 Screening low molecular weight compounds for modulation of fibroblast growth factor activity such as mitogenesis of receptor expressing cells as well as competitive binding with heparin to receptor and dimerization |
| 04/06/1999 | US5891652 Methods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptides |
| 04/06/1999 | US5891650 Kinase receptor activation assay |
| 04/06/1999 | US5891648 Reaction-based selection for expression of and concentration of catalytic moieties |
| 04/06/1999 | US5891646 Detecting g protein coupled receptor (gpcr) activity in vivo and in vitro. |
| 04/06/1999 | US5891645 Porcine E-selectin |
| 04/06/1999 | US5891641 Assay for disease related conformation of a protein |
| 04/06/1999 | US5891639 Telomerase activity assays |
| 04/06/1999 | US5891638 A method of detecting alk-7 nucleic acid or polypeptide in a sample; and kits containing nucleic acid probes or antibodies. |
| 04/06/1999 | US5891637 Construction of full length cDNA libraries |
| 04/06/1999 | US5891636 Processes for genetic manipulations using promoters |
| 04/06/1999 | US5891635 Protease assays |
| 04/06/1999 | US5891634 Transfection of enteric parasites |
| 04/06/1999 | US5891632 Method and device for fragment trace data display in DNA base sequencing |
| 04/06/1999 | US5891631 Methods relating tosterol regulatory element binding proteins |
| 04/06/1999 | US5891629 Compositions for improving RNase cleavage of base pair mismatches in double-stranded nucleic acids |
| 04/06/1999 | US5891625 Use of nucleic acid analogues in the inhibition of nucleic acid amplification |
| 04/06/1999 | US5891442 Containing foreign dna from infectious bursal disease virus |
| 04/06/1999 | US5891437 Antigen associated with type I diabetes mellitus |
| 04/06/1999 | US5891436 The present invention thus provides the basis of an extremely sensitive and specific diagnostic elisa for anti-70 kd antibodies found in pbc. |
| 04/06/1999 | US5891432 Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same |
| 04/06/1999 | US5891431 Biopesticides |
| 04/06/1999 | US5891430 Diabetogene rad: a type II diabetes specific gene |
| 04/06/1999 | US5891429 Recombinant human granulocyte-macrophage-colony stimulating factor (GM-CSF) |
| 04/06/1999 | US5891313 Entrapment of nucleic acid sequencing template in sample mixtures by entangled polymer networks |
| 04/06/1999 | CA2106301C Oligosaccharide enzyme substrates and inhibitors: method and compositions |
| 04/06/1999 | CA2095836C Cytokine immunoconjugates |
| 04/06/1999 | CA2064705C Methods for culturing hcv in eukaryotic cells |
| 04/06/1999 | CA2018273C Thermally stable cytosine deaminase |
| 04/06/1999 | CA2000159C Bacterial detection by phage transduction of detectable phenotype |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/06/1999 | CA1340483C Diagnosis of retinoblastoma |
| 04/06/1999 | CA1340480C Transient expression system for producing recombinant protein |
| 04/02/1999 | CA2246045A1 The alteration of the substrate specificity of enzymes |
| 04/01/1999 | WO1999015899A1 Immunoassay to detect herpesvirus specific igm |
| 04/01/1999 | WO1999015897A1 Subtractive protein screening for gene identification |
| 04/01/1999 | WO1999015896A1 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material |
| 04/01/1999 | WO1999015876A1 Apparatus and method for transferring liquids |
| 04/01/1999 | WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes |
| 04/01/1999 | WO1999015702A1 Normalized nucleic acid libraries and methods of production thereof |
| 04/01/1999 | WO1999015700A1 Methods of evaluating transplant rejection |
| 04/01/1999 | WO1999015699A1 Translational frameshift based drug screening assay |
| 04/01/1999 | WO1999015698A2 Method for synthesising and amplifying nucleic acids |
| 04/01/1999 | WO1999015697A1 ALLELIC VARIANTS OF THE PHOSPHOLIPASE C-η1 GENE ASSOCIATED WITH BIPOLAR DISORDER |
| 04/01/1999 | WO1999015687A1 Multicomponent polynucleotide complex for high efficiency cell transfection |
| 04/01/1999 | WO1999015686A1 Plasmids for construction of eukaryotic viral vectors |
| 04/01/1999 | WO1999015685A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 04/01/1999 | WO1999015684A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | WO1999015683A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 04/01/1999 | WO1999015682A2 Gene silencing materials and methods |
| 04/01/1999 | WO1999015681A1 Control pop dehiscence or shatter |
| 04/01/1999 | WO1999015680A1 Control of plant abscission and pod dehiscence or shatter |
| 04/01/1999 | WO1999015679A1 Petal-specific promoter and method for obtaining plants having flowers with no petals |
| 04/01/1999 | WO1999015678A1 Microspore-specific promoter and method for obtaining hybrid plants |
| 04/01/1999 | WO1999015677A1 Method for gene transfer using bcl2 and compositions useful therein |
| 04/01/1999 | WO1999015676A1 A novel generation of cloned horseshoe crab recombinant factor c for detection and removal of endotoxin |
| 04/01/1999 | WO1999015675A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/01/1999 | WO1999015674A2 Transgenic plants having early-ripening and completely withering aerial parts |
| 04/01/1999 | WO1999015673A1 MEMBRANE-BOUND GLUCONATE DEHYDROGENASE, GENE SEQUENCE ENCODING THE SAME AND PRODUCTION OF 2-KETO-D-GLUCONATE USING TRANSFORMED RECOMBINANT $i(E-coli) |
| 04/01/1999 | WO1999015672A1 Attenuated respiratory syncytial viruses |
| 04/01/1999 | WO1999015671A1 Hepatitis b virus polypeptides |
| 04/01/1999 | WO1999015670A1 LKTA DELETION MUTANT OF $i(P. HAEMOLYTICA) |
| 04/01/1999 | WO1999015669A2 Clostridium toxin, and method for preparing immunogenic compositions |
| 04/01/1999 | WO1999015668A2 Banana proteins, dna, and dna regulatory elements associated with fruit development |
| 04/01/1999 | WO1999015667A1 Pre-harvest sprouting |
| 04/01/1999 | WO1999015666A2 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof |
| 04/01/1999 | WO1999015665A2 Mutants of thyroid stimulating hormone and methods based thereon |
| 04/01/1999 | WO1999015664A1 Insulin-like polypeptide and uses therefor |
| 04/01/1999 | WO1999015663A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 04/01/1999 | WO1999015662A1 Telomere repeat binding factors and diagnostic and therapeutic use thereof |
| 04/01/1999 | WO1999015661A1 Cell growth regulator |
| 04/01/1999 | WO1999015660A1 G-protein coupled glycoprotein hormone receptor hg38 |
| 04/01/1999 | WO1999015659A2 Human ubiquitin-conjugating enzymes |
| 04/01/1999 | WO1999015658A2 Human regulatory molecules |
| 04/01/1999 | WO1999015657A2 53bp2 complexes |
| 04/01/1999 | WO1999015656A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | WO1999015655A1 Dna vaccination against cholesterol ester transfer protein in the treatment of atherosclerosis |
| 04/01/1999 | WO1999015654A2 Tie receptor tyrosine kinase ligand homologues |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015652A1 Megsin protein |
| 04/01/1999 | WO1999015651A1 Synthetic polypeptide for diagnosing and treating prion-related diseases |
| 04/01/1999 | WO1999015650A1 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
| 04/01/1999 | WO1999015649A2 Composition and method for enhancing paracellular transport across cell layers |
| 04/01/1999 | WO1999015648A1 Antisense oligonucleotides against thymidylate synthase |
| 04/01/1999 | WO1999015647A1 A potential effector for the grb7 family of signalling proteins |
| 04/01/1999 | WO1999015646A1 Dna promoter sequences derived from banana bunchy top virus |
| 04/01/1999 | WO1999015645A1 Method for isolating dna |